LEGN compared with AVBP: revenue, margins and what each company keeps, and the suppliers and customers both name

LEGNLegend Biotech Corp

Mkt capRevenueRevenue

AVBPArriVent BioPharma, Inc.

Mkt capRevenueRevenue

Compare

LEGNLegend Biotech Corp

AVBPArriVent BioPharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

LEGN: latest quarter not drawable. AVBP: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LEGN 1

JNJJanssencustomer

Shared 0

No shared counterparties.

Only AVBP 8

—Shanghai Allist Pharmaceuticalsunlistedsupplier

—Lepu Biopharmaunlistedsupplier

—Aarvik Therapeuticsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Jiangsu Alphamab Biopharmaceuticalsunlistedsupplier

4 more · AVBP chain ›

Price

rebased to 0%

LEGN, solidAVBP, dashed

LEGNLegend Biotech Corp

21.63▼−3.03%· post 21.63

Mkt cap$4.0B

AVBPArriVent BioPharma, Inc.

14.93▼−6.41%· post 14.72

ClosedOct 30 '26

Mkt cap$707.9M

Compare

ClosedOct 30 '26

LEGNLegend Biotech Corp

AVBPArriVent BioPharma, Inc.

21.63▼−3.03%post 21.63

Price

14.93▼−6.41%post 14.72

$4.0B

Mkt cap

$707.9M

LEGN21.63▼−3.03%vsAVBP14.93▼−6.41%ClosedOct 30 '26